A multicentre randomised clinical trial to evaluate the benefit of testing for thrombophilia following a first venous thromboembolism: The NOSTRADAMUS study;Een multicentrisch gerandomiseerd klinisch onderzoek naar her nut van trombofilietests bij een eerste veneuze trombo-embolie: Het NOSTRADAMUS- onderzoek

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 6, 2007, Pages 371-373

  Cohn, D M ^a   Middeldorp, S ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOPHILIA; TREATMENT DURATION; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; NETHERLANDS; QUALITY OF LIFE; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 33847045923     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Anderson jr FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:933-8.
2. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000;83:657-60.
3. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. Arch Intern Med. 1997;157:1665-70.
4. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet. 1999;353:1167-73.
5. Lensing AW, Prandoni P, Prins MH, Büller HR. Deep-vein thrombosis. Lancet. 1990;353:479-85.
6. Middeldorp S, Prins MH, Büller HR. Geen indicatie voor trombofilieonderzoek bij patiënten met idiopathische veneuze trombo-embolie en hun familieleden. Ned Tijdschr Geneeskd. 2001;145:1047-51.
7. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):401S-28S.
8. Kwaliteitsinstituut voor de Gezondheidszorg CBO (CBO). Conceptrichtlijn 'Diagnostiek, preventie en behandeling van veneuze tromboembolie en secundaire preventie arteriële trombose'. Utrecht: CBO; 2006.